AI-guided personal diet plans for adults having a health check-up
Tests two kinds of AI diet guidance in adults at health screening.
Plain-language title generated from the registry record
Registry title: Agentic AI Personalized Dietary Management Study
Key facts
- Where
- Seoul, South KoreaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 90 years old?
Source: NCT07638241, who can take part
Where in South Korea
- Seoul National University Hospital Healthcare System Gangnam CenterSeoul, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Seoul National University Hospital
- Trial code
- NCT07638241
- Record updated
- 15 September 2026
- Original description
This randomized controlled trial aims to evaluate the effectiveness of an Agentic AI-based personalized dietary management algorithm among adults undergoing health screening. Participants will be assigned to a control group, a static goal AI intervention group, or an adaptive goal AI intervention group and followed for 12 weeks.Read full original descriptionShow less
Effectiveness of an Agentic AI-Based Personalized Dietary Management Algorithm in Health Screening Participants: A Randomized Controlled Trial
This randomized controlled trial aims to evaluate the effectiveness of an Agentic AI-based personalized dietary management algorithm among adults undergoing health screening. Participants will be assigned to a control group, a static goal AI intervention group, or an adaptive goal AI intervention group and followed for 12 weeks.
Inclusion: Adults aged 20 years or older; Individuals from the general population who underwent a health examination at the Seoul National University Hospital Healthcare System Gangnam Center; Individuals who are capable of independently using a smartphone and operating study-related applications or text messaging functions; Individuals without conditions that significantly interfere with standard dietary management, as specified in the exclusion criteria [Section 9.2 Exclusion Criteria].
Exclusion: End-stage renal disease or patients currently receiving dialysis; Individuals with recent major weight-related interventions or extreme body weight changes within the past 3 months, including:Bariatric surgery such as gastrectomy or gastric bypass surgery Newly initiated anti-obesity pharmacotherapy (e.g., semaglutide/Wegovy, tirzepatide/Mounjaro); Active cancer or currently undergoing chemotherapy or radiotherapy; Severe heart failure, liver cirrhosis, or hepatic insufficiency accompanied by varices, bleeding, ascites, hepatic encephalopathy, or jaundice; Malabsorption disorders such as Crohn's disease or short bowel syndrome; Diagnosed eating disorders or severe psychiatric disorders; Individuals unable to use a smartphone or study-related digital program/application, including those without a smartphone or unable to operate text messaging or application-based functions; Poorly controlled hyperthyroidism or hypothyroidism; Pregnant or breastfeeding women, or women who may become pregnant during study participation; Individuals considered by the investigator to have poor compliance potential or otherwise deemed unsuitable for participation in the clinical study.